Novel galanin receptor subtype specific ligand in depression like behavior

Neurochemical Research

Volumn 38, Issue 2, 2013, Pages 398-404

  Saar, Indrek ^a,b   Runesson, Johan ^b   Järv, Jaak ^a   Kurrikoff, Kaido ^a   Langel, Ülo ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Agonist; Depression; Galanin; Galaninreceptor type 2; GPCR; Neuropeptide

Indexed keywords

ADENYLATE CYCLASE; ANTIDEPRESSANT AGENT; G PROTEIN COUPLED RECEPTOR; GALANIN RECEPTOR; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; IMIPRAMINE; INOSITOL PHOSPHATE; LIGAND; NEUROPEPTIDE; NEUROTRANSMITTER; RECEPTOR SUBTYPE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; FEMALE; LOCUS CERULEUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DEPRESSION; FEMALE; GALANIN; HUMANS; LIGANDS; MALE; MICE; MICE, INBRED BALB C; PROTEIN BINDING; RANDOM ALLOCATION; RECEPTOR, GALANIN, TYPE 2;

ANIMALIA;

EID: 84876407438     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0933-8     Document Type: Article

References (26)

1. Tatemoto K, Rökaeus Å, Jornvall H, McDonald TJ, Mutt V (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 164(1):124-128
2. Lang R, Gundlach AL, Kofler B (2007) The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 115(2):177-207. doi: 10.1016/j.pharmthera.2007.05.009
3. Runesson J, Robinson JK, Sollenberg UE, Langel Ü (2009) Twenty-five years of galanin research. In: Howl S, Jones S (eds) Bioactive peptides. CRC Press, New York, pp 237-260
4. Ögren SO, Razani H, Elvander-Tottie E, Kehr J (2007) The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders. Physiol Behav 92(1-2):172-179. doi: 10.1016/j.physbeh.2007.05.022
5. Xu ZQ, Zhang X, Pieribone VA, Grillner S, Hökfelt T (1998) Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87(1):79-94
6. Ma X, Tong YG, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, Hökfelt T, Xu ZQ (2001) Effects of galanin receptor agonists on locus coeruleus neurons. Brain Res 919(1):169-174
7. Pieribone VA, Xu ZQ, Zhang X, Hökfelt T (1998) Electrophysiologic effects of galanin on neurons of the central nervous system. Ann NY Acad Sci 863:264-273
8. Thor KB, Kirby M, Viktrup L (2007) Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. Int J Clin Pract 61(8):1349-1355. doi: 10.1111/j.1742-1241.2007.01433.x
9. Mazarati AM, Baldwin RA, Shinmei S, Sankar R (2005) In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures. J Neurochem 95(5):1495-1503. doi: 10.1111/j.1471-4159.2005.03498.x
10. Barr AM, Kinney JW, Hill MN, Lu X, Biros S, Rebek J Jr, Bartfai T (2006) A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neurosci Lett 405(1-2):111-115. doi: 10.1016/j.neulet.2006.06.033
11. Swanson CJ, Blackburn TP, Zhang X, Zheng K, Xu ZQ, Hökfelt T, Wolinsky TD, Konkel MJ, Chen H, Zhong H, Walker MW, Craig DA, Gerald CP, Branchek TA (2005) Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci USA 102(48):17489-17494. doi: 10.1073/pnas.0508970102
12. Lu X, Barr AM, Kinney JW, Sanna P, Conti B, Behrens MM, Bartfai T (2005) A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci USA 102(3):874-879. doi: 10.1073/pnas.0408891102
13. Kuteeva E, Wardi T, Lundström L, Sollenberg U, Langel Ü, Hökfelt T, Ögren SO (2008) Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharmacology 33(11):2573-2585. doi: 10.1038/sj.npp.1301660
14. Cheng Y, Prusoff WH (1973) Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic-reaction. Biochem Pharmacol 22(23):3099-3108
15. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29(4-5):571-625
16. Runesson J, Saar I, Lundström L, Järv J, Langel Ü (2009) A novel GalR2-specific peptide agonist. Neuropeptides 43(3):187-192. doi: 10.1016/j.npep.2009.04.004
17. Kask K, Berthold M, Kahl U, Jureus A, Nordvall G, Langel Ü, Bartfai T (1998) Mutagenesis study on human galanin receptor GalR1 reveals domains involved in ligand binding. Ann NY Acad Sci 863:78-85
18. Lundström L, Sollenberg UE, Bartfai T, Langel Ü (2007) Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions. J Neurochem 103(5):1774-1784. doi: 10.1111/j.1471-4159.2007.04959.x
19. Church WB, Jones KA, Kuiper DA, Shine J, Iismaa TP (2002) Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificity. Protein Eng 15(4):313-323
20. Runesson J, Sollenberg UE, Jurkowski W, Yazdi S, Eriksson EE, Elofsson A, Langel Ü (2010) Determining receptor-ligand interaction of human galanin receptor type 3. Neurochem Int 57:804-811. doi: 10.1016/j.neuint.2010.08.018
21. Saar I, Runesson J, McNamara I, Järv J, Robinson JK, Langel Ü (2011) Novel galanin receptor subtype specific ligands in feeding regulation. Neurochem Int 58(6):714-720. doi: 10.1016/j.neuint.2011.02.012
22. Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, Hökfelt T (2001) Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci USA 98(17):9960-9964. doi: 10.1073/pnas.161293598161293598
23. Lundström L, Sollenberg U, Brewer A, Kouya PF, Zheng K, Xu X-J, Sheng X, Robinson JK, Wiesenfeld-Hallin Z, Xu Z-Q, Hökfelt T, Bartfai T, Langel Ü (2005) A galanin receptor subtype 1 specific agonist. Int J Pept Res Ther 11(1):17-27. doi: 10.1007/s10989-004-1717-z
24. Sollenberg UE, Lundström L, Bartfai T, Langel Ü (2006) M871 - a novel peptide antagonist selectively recognizing the galanin receptor type 2. Int J Pept Res Ther 12(2):115-119. doi: 10.1007/s10989-005-9008-x
25. Sollenberg UE, Runesson J, Sillard R, Langel Ü (2010) Binding of chimeric peptides M617 and M871 to galanin receptor type 3 reveals characteristics of galanin receptor-ligand interaction. Int J Pept Res Ther 16(1):17-22. doi: 10.1007/s10989-009-9197-9
26. Lu X, Lundström L, Bartfai T (2005) Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides 39(3):165-167. doi: 10.1016/j.npep.2004.12.013